Preliminary Programme


Oral Presentations on Basic Science (submitted abstracts)

Chairs: Konstantinos Poulas & Demetrios Kouretas


Opening remarks
Goals of the 3rd Scientific Summit on Tobacco Harm Reduction
Organizing Committee


Tobacco Control Policies – Do they work?
Chairs: Michael Toumbis & Karl E. Lund
Global tobacco control efforts — What has been done so far? Mata Tsikrika
How are we addressing youth appeal and access? Lion Shahab
Smoking Cessation: Best practices to improve quit rates, Georgios S. Goumas
e-Cigarettes for smoking cessation, Paraskevi A. Katsaounou


Novel nicotine-delivering products: toxicology, regulation, and health issues

Chairs: Demetrios Kouretas & Konstantinos Poulas


Break – Matchmaking


Keynote lecture
Risk proportionate regulation and the science to support it: How rapidly can we end the epidemic of cigarette-caused disease? David T. Sweanor J.D.

Chair: Ignatios Ikonomidis


Public Health Policy and Regulation – What is expected in the future?

Chairs: Panos Vardas & David T. Sweanor J.D.

Longitudinal evaluation of Harm Reduction strategies worldwide, Karl Fagerström
What standards should authorities apply to alternative nicotine products to address challenges without losing potential benefits to adult smokers? Martin Dockrell
Public health risk communication: the FDA example, Clive Bates


Clinical Assessment and Research

Chairs: Peter Harper & Ignatios Ikonomidis

– Update on e-cigarettes publications: Safety and effects on smokers, nonsmokers and youth, Konstantinos Farsalinos
– Potential to reduce the risk of smoking-related diseases when switching from smoking to the tobacco heating system, Christelle Haziza
– Acute effects of heat-not-burn versus standard cigarette smoking in smokers, Charalambos Vlachopoulos
– Novel smoking products and cardiovascular risk, Giuseppe Biondi Zoccai


Hot topic
COVID-19 and nicotinic cholinergic system: an interaction which affects Public Health, Konstantinos Poulas & Konstantinos Farsalinos


Keynote lecture
Could the scientific and medical community play a role in making policy makers to reconsider the tobacco control strategies? David Khayat

Chair: Anastasia Barbouni


Panel Discussion
Should Tobacco Harm Reduction become a Public Health Policy tool globally?

Chair: Panos Vardas

Panelists: Charmaine Gauci, Karl E. Lund, Alex Wodak,
Stanimir Hasardzhiev, Karl Fagerstrom, Fernando Fernandez Bueno


Panel Discussion
The doctor’s dilemma:
Providing guidance on alternative smoking products to adult smokers amid controversy and change

Chairs: Dimitri Richter & Anastasia Barbouni

Panelists: Michael G. Toumbis, Peter Harper, & TBA


Break – Matchmaking


Panel Discussion
Tobacco Harm Reduction in low- and middle-income countries

Chair: Nimesh G. Desai

Panelists: Fares Mili, Sharifa Ezat Wan Puteh, & TBA


Panel Discussion
Bioethics: Smokers right on credible information

Chairs: Monica Gorgulho & Nikos Dedes

Panelists: TBA


Smoking Harm Reduction Society Announcement
– Mission, Values, Principles
– Position Statement & Voting


Closing Remarks

Organizing Committee